For more information or confidential assistance
se habla español

Janssen Accused of Manipulating Published Risperdal Study

Dr. David Kessler, the former head of the U.S. Food and Drug Administration, claims that a medical article, which was co-authored by SickKids hospital’s top pediatrician, understated the serious nature and rate of Risperdal side effects in younger patients. The authors of the 2003 article were allegedly manipulated by the drug company Janssen,... Read more »

Risperdal Lawsuit Claims Promotion of Off-Label Use

A resident of Minnesota has filed a Risperdal lawsuit, alleging that the medication resulted in gynecomastia and other severe complications. The lawsuit, which was filed in the U.S. District Court for the District of Minnesota, names Johnson & Johnson Company and Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, as... Read more »

Risperdal Lawsuit over Gynecomastia Filed in Louisiana

Another Risperdal lawsuit over gynecomastia has been filed, this time in Louisiana. Karon-Jahlil Williams v. Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development, L.L.C. (Case # 5:14-cv-03354) was filed on December 2, 2014 in the US. District Court for the Western District of Louisiana (Shreveport Division). The... Read more »

Risperdal Gynecomastia Lawsuits Poised for Trial

As the wave of lawsuits involving antipsychotic drug Risperdal continues to gain momentum, several key cases are slated for trial in the coming months in Pennsylvania state court. These suits involve allegations made on behalf of males who suffered excessive breast development after taking the medication in their youth. Johnson &... Read more »